Frontier Medicines - Crunchbase Company Profile & Funding

Q: Who invested in Frontier Medicines?

Frontier Medicines has 13 investors including Deep Track Capital And ArrowMark Partners.

Q: How much funding has Frontier Medicines raised to date?

Frontier Medicines has raised obfuscated.

Overview

Frontier Medicines

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+4 more milestones

See more interactive data and historical milestones on desktop for the best experience

About Frontier Medicines

CB Rank

12868

Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines.

Founded

obfuscation

Private

Series C

San Francisco, California, United States

101-250

frontiermeds.com/

Biopharma

Biotechnology

Life Science

Pharmaceutical

Precision Medicine

Therapeutics

Funding Rounds

Series C

OBF

obfuscation

Series C

OBF

obfuscation

Series B

OBF

obfuscation

Key People

Chris Varma: Co-founder and CEO
Past Role: Blueprint Medicines, President and CEO
Gerardo Ubaghs Carrión: Chief Financial Officer

Details

Legal Name

Frontier Medicines Corporation

Operating Status

Active

Company Type

For Profit

Founders

Chris Varma, Daniel Nomura

About the Company

Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines. Its platform integrates advanced computational approaches and machine learning to discover and pharmacologically target new binding pockets on proteins that make them accessible to small-molecule drug discovery and

development.

Phone Number

650 457 1005

Contact Email

contact@frontiermeds.com

Predictions & Insights

Growth Insight

See this Growth Insight

Frontier Medicines is

Lorem

to be growing

Top Contributing Factors

Operations Expansion

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

The Frontier™ Platform

A drug discovery platform using chemoproteomics, covalent drug discovery, and machine learning to identify and develop small molecule therapeutics against previously undruggable protein targets.

FMC-376 (Dual KRAS G12C Inhibitor)

An orally bioavailable small molecule that inhibits both active and inactive forms of the KRAS G12C mutation to treat cancers such as non-small cell lung, colorectal, and pancreatic cancers.

Research & Development

Frontier Medicines is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series C - Frontier Medicines	2	obfuscated obfuscation	—	Series C
obfuscated obfuscation	Series C - Frontier Medicines	2	obfuscated obfuscation	—	Series C
obfuscated obfuscation	Series C - Frontier Medicines	2	obfuscated obfuscation	—	Series C
obfuscated obfuscation	Series C - Frontier Medicines	2	obfuscated obfuscation	—	Series C
obfuscated obfuscation	Series C - Frontier Medicines	2	obfuscated obfuscation	—	Series C

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series C - Frontier Medicines	2	obfuscated obfuscation	—	Series C
obfuscated obfuscation	Series C - Frontier Medicines	2	obfuscated obfuscation	—	Series C
obfuscated obfuscation	Series C - Frontier Medicines	2	obfuscated obfuscation	—	Series C
obfuscated obfuscation	Series C - Frontier Medicines	2	obfuscated obfuscation	—	Series C
obfuscated obfuscation	Series C - Frontier Medicines	2	obfuscated obfuscation	—	Series C

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Deep Track Capital	—	Series C - Frontier Medicines	—
Deep Track Capital	—	Series C - Frontier Medicines	—
Deep Track Capital	—	Series C - Frontier Medicines	—
Deep Track Capital	—	Series C - Frontier Medicines	—
Deep Track Capital	—	Series C - Frontier Medicines	—